AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00254-07v1
51/8/2888    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korycka-Machala, M.
Right arrow Articles by Dziadek, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korycka-Machala, M.
Right arrow Articles by Dziadek, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2007, p. 2888-2897, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00254-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Evaluation of NAD+-Dependent DNA Ligase of Mycobacteria as a Potential Target for Antibiotics{triangledown}

Malgorzata Korycka-Machala,1 Ewelina Rychta,2 Anna Brzostek,1 Heather R. Sayer,3 Anna Rumijowska-Galewicz,1 Richard P. Bowater,3 and Jaroslaw Dziadek1*

Centre of Medical Biology, Polish Academy of Sciences, Lodz, Poland,1 Department of Genetics of Microorganisms, University of Lodz, Lodz, Poland,2 School of Biological Sciences, University of East Anglia, Norwich, United Kingdom3

Received 20 February 2007/ Returned for modification 20 April 2007/ Accepted 23 May 2007

Mycobacteria contain genes for several DNA ligases, including ligA, which encodes a NAD+-dependent enzyme that has been postulated to be a target for novel antibacterial compounds. Using a homologous recombination system, direct evidence is presented that wild-type ligA cannot be deleted from the chromosome of Mycobacterium smegmatis. Deletions of native ligA in M. smegmatis could be obtained only after the integration of an extra copy of M. smegmatis or Mycobacterium tuberculosis ligA into the attB site of the chromosome, with expression controlled by chemically inducible promoters. The four ATP-dependent DNA ligases encoded by the M. smegmatis chromosome were unable to replace the function of LigA. Interestingly, the LigA protein from M. smegmatis could be substituted with the NAD+-dependent DNA ligase of Escherichia coli or the ATP-dependent ligase of bacteriophage T4. The conditional mutant strains allowed the analysis of the effect of LigA depletion on the growth of M. smegmatis. The protein level of the conditional mutants was estimated by Western blot analysis using antibodies raised against LigA of M. tuberculosis. This revealed that a strong overproduction or depletion of LigA did not affect the growth or survival of mycobacteria under standard laboratory conditions. In conclusion, although NAD+-dependent DNA ligase is essential for mycobacterial viability, only low levels of protein are required for growth. These findings suggest that very efficient inhibition of enzyme activity would be required if NAD+-dependent DNA ligase is to be useful as an antibiotic target in mycobacteria. The strains developed here will provide useful tools for the evaluation of the efficacy of any appropriate compounds in mycobacteria.


* Corresponding author. Mailing address: Centre of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-231 Lodz, Poland. Phone: 48 42 2723610. Fax: 48 42 2723630. E-mail: jdziadek{at}cbm.pan.pl

{triangledown} Published ahead of print on 4 June 2007.


Antimicrobial Agents and Chemotherapy, August 2007, p. 2888-2897, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00254-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.